Partner Ecosystem Drives Collaboration
World-leading life science data from Thomson Reuters Cortellis now available to third-party developers.
The Intellectual Property & Science business of Thomson Reuters has launched Partner Ecosystem, a new initiative that provides access to Thomson Reuters life sciences information through application-specific solutions developed with third-party partners. Through Partner Ecosystem, , third-party developers take advantage of the Thomson Reuters Cortellis open architecture to access the company’s content and technology, creating custom solutions that meet the needs of their customers.
These solutions include Thomson Reuters market-leading ontologies, biological target information and additional critical information supporting pharmaceutical business development and competitive intelligence projects. The flexible approach to information delivery enables companies to integrate Thomson Reuters trusted drug pipeline data seamlessly into the daily workflow, delivering on-point information so users can quickly make informed decisions.
In addition, partners gain access to the Cortellis Developer Center, a forum where client and third-party developers collaborate to share ideas, best practices, and discuss new applications, as well as obtain technical support from Thomson Reuters technology and content experts.
“We understand the important role our partners play in working with us to support the success of our mutual customers. Partner Ecosystem, is a step toward providing the infrastructure and collaboration environment necessary to develop solutions that support the drug R&D process,” said Jon Brett-Harris, executive vice president of Life Sciences at Thomson Reuters. ”Partner Ecosystem, , alongside our portfolio of other advanced solutions, provides the life sciences industry with the necessary tools and information to help address the challenges our customers face.”